[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI853585A0 - Foerfarande foer framstaellning av aromatiska 1,4-oxazepinoner och -tioner. - Google Patents

Foerfarande foer framstaellning av aromatiska 1,4-oxazepinoner och -tioner.

Info

Publication number
FI853585A0
FI853585A0 FI853585A FI853585A FI853585A0 FI 853585 A0 FI853585 A0 FI 853585A0 FI 853585 A FI853585 A FI 853585A FI 853585 A FI853585 A FI 853585A FI 853585 A0 FI853585 A0 FI 853585A0
Authority
FI
Finland
Prior art keywords
oxazepinoner
aromatiska
tioner
och
foerfarande foer
Prior art date
Application number
FI853585A
Other languages
English (en)
Other versions
FI853585L (fi
Inventor
Young Sek Lo
Jr Albert Duncan Cale
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of FI853585A0 publication Critical patent/FI853585A0/fi
Publication of FI853585L publication Critical patent/FI853585L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI853585A 1984-09-19 1985-09-18 Foerfarande foer framstaellning av aromatiska 1,4-oxazepinoner och -tioner. FI853585L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/652,017 US4610819A (en) 1984-09-19 1984-09-19 Process for the preparation of aromatic-1,4-oxazepinones and thiones

Publications (2)

Publication Number Publication Date
FI853585A0 true FI853585A0 (fi) 1985-09-18
FI853585L FI853585L (fi) 1986-03-20

Family

ID=24615185

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853585A FI853585L (fi) 1984-09-19 1985-09-18 Foerfarande foer framstaellning av aromatiska 1,4-oxazepinoner och -tioner.

Country Status (20)

Country Link
US (1) US4610819A (fi)
EP (1) EP0175570A3 (fi)
JP (1) JPS6178789A (fi)
KR (1) KR900003852B1 (fi)
AU (2) AU586440B2 (fi)
CA (1) CA1277983C (fi)
DK (1) DK423485A (fi)
ES (1) ES8802305A1 (fi)
FI (1) FI853585L (fi)
GR (1) GR852247B (fi)
HU (2) HU195485B (fi)
IL (1) IL76243A (fi)
IN (1) IN162290B (fi)
NO (1) NO853665L (fi)
NZ (1) NZ213523A (fi)
PH (2) PH22955A (fi)
PL (2) PL150760B1 (fi)
PT (1) PT81157B (fi)
YU (2) YU142785A (fi)
ZA (1) ZA856527B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746655A (en) * 1987-06-10 1988-05-24 A. H. Robins Company, Incorporated Fused aromatic-spiropiperidine oxazepinones(and thiones)
GB8727385D0 (en) * 1987-11-23 1987-12-23 Lundbeck & Co As H Heterocyclic compounds
US11649218B2 (en) 2018-03-09 2023-05-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794639A (en) * 1966-03-10 1974-02-26 Squibb & Sons Inc Benzoxazepines and benzothiazepines
DE3382028D1 (de) * 1982-09-30 1991-01-10 Robins Co Inc A H Kondensierte aromatische oxazepinone und sulphuranaloge, ihrer herstellung und verwendung als histamin-antagonist.
ZA836994B (en) * 1982-09-30 1984-05-30 Robins Co Inc A H Fused aromatic oxazepinones and sulfur analogs thereof

Also Published As

Publication number Publication date
PH22955A (en) 1989-02-03
PH23204A (en) 1989-06-06
EP0175570A2 (en) 1986-03-26
YU144187A (en) 1988-10-31
DK423485D0 (da) 1985-09-18
AU586440B2 (en) 1989-07-13
AU4767385A (en) 1986-03-27
PL255423A1 (en) 1987-05-18
IL76243A0 (en) 1986-01-31
KR860002484A (ko) 1986-04-26
NZ213523A (en) 1989-08-29
PT81157B (pt) 1987-10-20
FI853585L (fi) 1986-03-20
GR852247B (fi) 1986-01-17
HUT40426A (en) 1986-12-28
JPS6178789A (ja) 1986-04-22
DK423485A (da) 1986-03-20
US4610819A (en) 1986-09-09
ES8802305A1 (es) 1987-03-16
AU4004789A (en) 1989-12-07
IL76243A (en) 1990-07-26
CA1277983C (en) 1990-12-18
HU195485B (en) 1988-05-30
ES547084A0 (es) 1987-03-16
NO853665L (no) 1986-03-20
KR900003852B1 (ko) 1990-06-02
IN162290B (fi) 1988-04-23
EP0175570A3 (en) 1988-07-20
PL147855B1 (en) 1989-08-31
HUT42070A (en) 1987-06-29
PT81157A (en) 1985-10-01
HU194245B (en) 1988-01-28
YU142785A (en) 1988-02-29
PL150760B1 (en) 1990-06-30
ZA856527B (en) 1986-04-30

Similar Documents

Publication Publication Date Title
FI853193A0 (fi) Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat.
FI850778L (fi) Foerfarande foer minskande av no x-halten i virvelskiktbraennanordningar.
FI853255L (fi) Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin.
FI852616A0 (fi) Foerfarande foer uppvaermning av tjockvaeggiga glasroer, jaemte anordning.
MX21592A (es) 1,3-oxazolidin-2-ona.
FI853837L (fi) Foerfarande foer framstaellning av isolerande, poroesa, formade byggelement.
FI853686L (fi) Foerfarande foer framstaellning av 2,4 -diklor-5-fluorbensoesyra.
FI852899L (fi) Foerfarande foer framstaellning av fenylsubstituerade 2,4,6,8-nonatetraensyror.
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
FI86060B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-naftalendioner.
DE3586745D1 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
FI853421L (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/ hept-2-enderivat.
FI855182A (fi) Foerfarande foer framstaellning av 1,3 -disubstituerade tetrahydropyridiner.
FI853585L (fi) Foerfarande foer framstaellning av aromatiska 1,4-oxazepinoner och -tioner.
FI850604L (fi) Anordning foer styckevis tvaermaetning av laongstraeckta foeremaol, foeretraedesvis virkesstycken.
FI853287L (fi) Nytt foerfarande foer framstaellning av 6-substituerad-furo-(3,4-c)-pyridinderivat.
FI852372A0 (fi) Foerfarande foer framstaellning av substituerade 1,3-dioxanderivat.
FI841632A (fi) Foerfarande foer framstaellning av laett instaellbara, haollbara anod- och jaernfoerelseelektrodkomponenter foer katodiskt skydd.
FI842639A0 (fi) Acylderivat av 1,4,3,6-dianhydro- hexitol.
FI843391A (fi) Foerfarande foer framstaellning av osymmetriska 1,4-dihydropyridin dikarboxylsyraestrar.
FI902521A0 (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 6,6-etylen-15,16-metylen-3-oxo-17a-pregn-4-en-21,17 -karbolaktoner.
FI844032L (fi) Av en styv skiva framstaelld, hoprullbar cellskivvaegg.
FI843537L (fi) Hoeghaollfast, svetsbart staol foer framstaellning av fasongjutstycken.
FI850668A0 (fi) Anordning foer behandling av roekgaser, speciellt avgaser.
FI902192A0 (fi) Foerfarande foer framstaellning av 1,3-dihydro-4-pyridinyl-2h-imidazol-2-oner.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: A.H. ROBINS COMPANY, INCORPORATED